Clinical Trials
12 trialsNCT07337785 2026-05-12
CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases
Tongji Hospital
Phase EARLY_PHASE1 Recruiting
NCT07526493 2026-05-12
Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With Relapsed/Refractory Antibody-Mediated Neurological Autoimmune Diseases.
Tongji Hospital
Phase 1 Recruiting
NCT04698421 2026-03-19
EXPLAINEUR
University Hospital, Toulouse
Recruiting
NCT06626919 2026-02-25
A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
Arcellx, Inc.
Phase 1 Recruiting
NCT04806620 2026-01-22
Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
Brain Inflammation Collaborative
Recruiting
NCT06939166 2025-12-15
Universal Chimeric Antigen Receptor T-Cell (UCAR T-cell) Therapy Targeting CD19/B Cell Maturation Antigen (CD19/BCMA) in Patients With r/r Neurological Autoimmune Diseases
Tianjin Huanhu Hospital
Phase EARLY_PHASE1 Recruiting
NCT06867991 2025-07-15
RADIA
The First People's Hospital of Changzhou
Phase 3 Recruiting
NCT06941584 2025-04-24
NAD-AIRE
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Recruiting
NCT05017142 2024-12-16
Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)
University of Bern
Recruiting
NCT06502015 2024-11-20
Biomarkers in Autoimmune Disease of Nervous System
Tongji Hospital
Recruiting
NCT04561557 2024-10-30
CARTinNS
Tongji Hospital
Phase EARLY_PHASE1 Recruiting
NCT05214612 2024-07-31
Predictors and Prognostic Factors of Myasthenia Gravis Outcome
Assiut University
Recruiting